Global events organizer Hyve Group has announced the acquisition of the Health Grown Advisory Network (HGAN), a US-based platform that connects healthcare innovators with investors and strategic partners. The deal marks Hyve’s third investment in the healthcare sector, following its previous acquisitions of HLTH and Behavioural Health Tech.
The move further strengthens Hyve’s growing healthcare division and aligns with its strategy of expanding into high-growth sectors that offer year-round engagement opportunities.
Founded by Josh Riff, HGAN facilitates connections between digital health companies and verified organizations, including employers and health plans. The platform also provides advisory services on marketing, brand positioning, and navigating complex healthcare ecosystems. Its clients include companies such as Spring Health, Virta, Rightway, and Maven, many of which already participate in Hyve’s flagship healthcare events like HLTH, ViVE, and Behavioural Health Tech.
According to Hyve, the acquisition introduces a new advisory component to its healthcare portfolio, creating more avenues for curated connections beyond the traditional event cycle. The company has indicated that this model could be extended to other industries within its global event portfolio.
Mark Shashoua, CEO of Hyve, said, “By integrating this deeper, high-touch approach with the HLTH product suite, we’re building a stronger, more diversified offering that delivers value all year round.”
HGAN’s founder Josh Riff will continue to lead the business under Hyve’s ownership. Commenting on the acquisition, Riff said, “This partnership delivers exactly what we’ve been building toward — a platform that transcends traditional conference boundaries. Instead of a few touch points a year, we aim to create continuous, meaningful dialogue among healthcare innovators and partners so that the ultimate beneficiary is the health consumer.”
Riff added that Hyve’s vision aligns closely with HGAN’s mission, noting, “Having spent time getting to know Hyve and its leaders, it’s abundantly clear that this is the right step for HGAN and healthcare innovation.”
The acquisition of HGAN marks Hyve’s sixth overall investment since launching its GO27 growth and optimisation plan last year, underscoring the company’s continued commitment to building a diversified and innovation-driven global events portfolio.
